Company description

Delivering better treatments
Camurus is Swedish research-based pharmaceutical company committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New drug products are based on our proprietary FluidCrystal® drug delivery technologies with the purpose to deliver improved quality of life, treatment outcomes and resource utilization. The company’s share is listed on Nasdaq Stockholm under the ticker “CAMX”. Camurus has approximately 75 employees with the head office located in Lund. The corporate culture is driven by innovation, strong collaboration internally and externally, ownership by everyone, quality, and passion about realizing our ideas and goals.
The cornerstones of our operations are innovation and efficient development of therapeutics with the potential to significantly improve the treatment and quality of life of patients with severe and chronic diseases. Our progress is accomplished thanks to our skilled, professional and dedicated teams and our unique technologies.
Our development create value across the pharmaceutical development cycle, from early programs to partnerships with international pharmaceutical companies. To maximize the value creation for our products, we are building our own European commercial organization with an initial focus on the opioid dependence market and other specialty markets with suitable dynamics and a concentrated prescriber base.
For more information visit http://www.camurus.com.

Technologies
FluidCrystal® - smart and versatile drug delivery
Camurus FluidCrystal® technologies are all based on special combinations of endogenous polar lipids that spontaneously form liquid crystal nanostructures in aqueous environments; at tissue surfaces or in the body. By combining these with active ingredients with proven efficacy and safety profiles, new patented medicines are developed at significantly lower cost and risk, compared with the development of new medicines.

CAM 2038 Opioid dependence
Transforming Opioid dependence treatment
Opioid dependence is serious, chronic, relapsing disease. It is a growing global health problem and the largest burden to society of all drugs. Medication assisted treatment (MAT) with daily buprenorphine and methadone is considered standard of care and effective but is also associated with limitations such as poor treatment adherence, misuse and diversion.
CAM2038 includes two long-acting subcutaneous buprenorphine investigational products for treatment of opioid dependence. The product candidates are based on Camurus’ proprietary FluidCrystal® injection depot technology and are intended for either weekly (q1w) or monthly (q4w) administration, each in multiple doses to allow individualized treatment of patients with opioid dependence. CAM2038 has the potential to free patients from the burden and stigma associated with the daily, often supervised, distribution and administration of medication.
The investigational products will be provided in prefilled syringes with thin needles, designed for convenient administration by healthcare personnel to ensure proper delivery and treatment compliance, and to minimize the risks of diversion, abuse, misuse, and accidental pediatric exposure. By reduced dosing frequency and thereby costs of treatment under supervision, as well as by improved treatment compliance, CAM2038 also has the potential to generate substantial savings for healthcare and society.

CAM2038 – Key target attributes
• Improved treatment adherence
• Reduced frequency of administrations – from 365 times to 12 times per year
• Minimized risk of diversion and misuse
• Eliminates risk of accidental pediatric exposure
• Flexible dosing and adjustable duration allow individualized therapy in all treatment phases
• Blocks the effects of illicit opioids

 

Medical Science Lead Denmark, Camurus

The position Medical Science Lead
The Medical Science Lead (MSL) is responsible for providing medical and scientific support externally to customers and internally to other functions in the company. In collaboration with the Regional Head of Medical Affairs, the Medical Science Lead is responsible for management of key opinion leaders in the area. The Medical Science Lead is part of and assist the global medical affairs organization as needed at national and international meetings and conferences.

The MSL is a key player in the Nordic team aiming for a successful launch of CAM2038, a novel and innovative treatment for opioid dependence. The MSL will work in a close cross functional collaboration with the Country Lead Sweden/Denmark, Key Account Management, Market Access and MSL colleagues in the Nordics, Europe and Globally.

The MSL position is home based with frequent travelling in Denmark, to the Swedish Camurus headquarters and occasionally abroad. The role requires fluent Danish and English as well as highly skilled in MS office. The position requires a valid and clean drivers license.

Role opportunities
• Launch CAM2038, a novel, innovative and valuable new treatment for opioid dependence in the market
• Be part of Camurus a research based and innovative Swedish Pharmaceutical company with a solid product portfolio, professional leadership and a solid financial situation. This mean short decision lines and an unique opportunity to influence
• As Medical Science Lead, be a key player with a broad responsibility in the cross functional Danish/Nordic team with a close collaboration with the Camurus headquarters in Lund (Sweden)
• Be part of an exciting journey with great opportunities for personal development.

Required experience, skills and profile

Education and knowledge
Bachelor of Science degree, or equivalent health related degree
Qualifying Educational degree or Completed relevant local certification to work with pharmaceutical product in the market
Drivers license
Fluent English oral & writing
MS Office (Word, Excel, PowerPoint)

Experience
• Solid experience from Medical Affairs or an adjoining medical role, ideally from a similar therapeutic area
• Experience from the pharmaceutical- or biopharmaceutical industry is required
• Fully cognizant of all relevant product related compliance requirements in Denmark
• Good working knowledge of field-based customer facing activities
• Experience from presenting medical- and health economic data for different interest groups (authorities, expert committees, physicians).

Competencies and skills
• Excellent verbal and written communication skills and interpersonal skills are required
• Able to work with autonomy and independence as well as a member of cross functional teams
• Demonstrated skills in delivering high quality scientific presentations
• Delivering Results and Meeting Customer Expectations
• Planning and Organising
• Applying Expertise and Technology within the medical affairs field
• Ability to travel (>50% of time)

Contact
For further information about the Medical Science Lead position please contact Jarl Molin, Recruitment consultant at PeakSearch. Apply for the position at http://www.peaksearch.se.

Jarl Molin
jarl.molin@peaksearch.se
+46 70 560 20 56
+46 8 545 00 100